7 November 2017 – A new interactive map showing malaria vector resistance, P. falciparum gene deletions, and antimalarial efficacy and resistance has been released. Such information is critical to inform appropriate malaria prevention, diagnosis and treatment strategies and to guide the development of new tools. WHO is seeking user feedback on this early release version available in English, French and Spanish.
3 November 2017 – The Malaria Policy Advisory Committee (MPAC), which brings together some of the world’s foremost experts on the disease, provides essential guidance to WHO for the development of global policy recommendations on malaria. Read the report of the latest MPAC meeting as well as a special series of interviews with the 5 women currently serving as members on the Committee.
31 October 2017 – In Nigeria’s Borno State, malaria is currently the leading cause of death and claims more lives than all other diseases combined. Children under the age of 5 are particularly vulnerable. WHO recently launched a special campaign in this state aimed at rapidly reducing the malaria burden among young children and, at the same time, protecting them against polio.
11 October 2017 – WHO is rolling out today the new Global Vector Control Response 2017-2030. The strategy, strongly supported by Member States at the World Health Assembly in May 2017, aims to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
29 September 2017 – Several news organizations have recently reported on the rapid spread of a “dangerous” malaria parasite that “cannot be killed with the main anti-malaria drugs” – a parasite they describe as “super malaria”. Dr Pedro Alonso, Director of the Global Malaria Programme, responds to the concerns raised in these reports in an online Q&A.
Areas of work
- Diagnostic testing
- Drug resistance and response
- Entomology and vector control
- Malaria elimination
- High-risk groups
- Malaria vaccine development
- Preventive therapies
Fact sheets and Q&As
- WHO fact sheet on malaria
- Q&A on the malaria vaccine implementation programme (MVIP)
- Q&A on the Phase 3 trial results for malaria vaccine RTS,S/AS01
- Q&A on artemisinin resistance
Mass drug administration for malaria
- Rectal artesunate for pre-referral treatment of severe malaria
- False-negative RDT results and implications of new reports of P. falciparum HRP 2/3 gene deletions
- Conditions for deployment of mosquito nets treated with a pyrethroid and piperonyl butoxide
- Malaria vector control policy recommendations and their applicability to product evaluation
- Framework for a national plan for monitoring and management of insecticide resistance in malaria vectors
Other recent publications
- Framework for a national vector control needs assessment
- Malaria Policy Advisory Committee meeting report (October 2017)
- Global vector control response 2017–2030
- Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round 7 (2015-2016)
Closing the prevention gap
World Malaria Report
Global Technical Strategy
Policy Advisory Committee
A word from the experts
Hear from some of the world-renowned researchers that guide WHO's malaria policies.
Changes to the WHO-FIND Malaria RDT Lot Testing Programme
Leaders at UN General Assembly step up commitments in the fight against malaria
Europe commits to staying malaria-free
WHO and partners take on malaria: the top killer in north-eastern Nigeria
WHO child health programme dries tears in the Democratic Republic of the Congo
Letter to partners
Malaria eradication on the agenda at the 141st WHO Executive Board meeting